ACCELERATING THE PRECLINICAL TESTING OF A PROMISING TARGETED THERAPEUTIC FOR TRIPLE-NEGATIVE BREAST CANCER

$1,158,742FY2020Defense Health AgencyDOD

Queensland University Of Technology, Brisbane

Investigators

ACCELERATING THE PRECLINICAL TESTING OF A PROMISING TARGETED THERAPEUTIC FOR TRIPLE-NEGATIVE BREAST CANCER · GrantIndex